You are here:

TB-Multimorbidity

This working group was formed to set up a community of practice in tuberculosis multimorbidity, aiming to develop and promote a strategic research, awareness, advocacy and policy agenda and initiatives on physical and mental multimorbidity in tuberculosis care. 

TB-Multimorbidity (TBMM) Working Group was formed to set up a community of practice in tuberculosis-multimorbidity aiming to develop and promote strategic research, awareness, advocacy and policy agenda and initiatives on physical and mental multimorbidity in Tuberculosis care. TB-MM Working Group will assemble researchers, practitioners and professionals to collaboratively focus on the advancement of implementation and operational research and practice, pertinent to addressing multimorbidity in tuberculosis. People diagnosed/cured with tuberculosis and comorbid conditions and their caretakers, being the most significant stakeholders, will also be included in the community of practice. 

The objectives of this working group  are:

1.   To create and sustain a platform to pursue improvement in prevention, recognition and management of multimorbid physical and mental conditions in TB, through discourse and exchange of ideas, experiences and proposals, promotion of awareness and dissemination of the best practices and evidence.

2.   To support and enhance the scope of collaborative research in TB multimorbidity through the formulation of an international research team and development of demonstration research project proposal/s for intervention/s for timely recognition and management of coexistent Non-Communicable Diseases in TB services and identification of pertinent funding sources.

3.   To enhance the research capacity of early and middle career researchers in the area of TB multimorbidity to support them as potential research leaders, and to contribute to the operational research training initiative of the Union. 

The key members of the group are Professor Kamran Siddiqi (University of York, UK), Dr Lloyd Friedman (Yale University School of Medicine USA) and Dr Alexander Jarde (Cochrane, France) in addition to many esteemed UNION members of this group.